Matthew Diaz

Trails Edge Capital Partners, Lp

Assets Managed

$436.528M

Holdings

Last Quarter

2026 - Q1

Filed Date

11d ago

Growth Rate

7.86%(2Q avg: 3.93%)

Sustained Growth

1 quarters

Portfolio positions

This chart displays the top 10 holdings in Trails Edge Capital Partners, Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 26 positions.

Assets under management

The assets under management (AUM) of Trails Edge Capital Partners, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 436.528M in assets, with a quarterly growth rate of 7.86% and a 2-quarter average growth rate of 3.93%. The portfolio is managed by Matthew Diaz, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
PCVX Vaxcyte Inc Recent Activity Decreased -10.16%	8.82%	$38.496M 662,470 shares@ $58.12 avg price	Decreased -10.16%
XENE Xenon Pharmaceuticals Inc Recent Activity Increased 7.19%	8.53%	$37.216M 640,000 shares@ $58.15 avg price	Increased 7.19%
DFTX Definium Therapeutics Inc Recent Activity New Position	7.53%	$32.85M 1.738M shares@ $18.91 avg price	New Position
LBRX Lb Pharmaceuticals Inc Recent Activity Decreased -5.46%	7.46%	$32.535M 1.319M shares@ $24.67 avg price	Decreased -5.46%
MIRM Mirum Pharmaceuticals Inc Recent Activity Increased 946.12%	7.06%	$30.791M 333,312 shares@ $92.39 avg price	Increased 946.12%
NRIX Nurix Therapeutics Inc Recent Activity	6.19%	$27.02M 1.743M shares@ $15.5 avg price
RVMD Revolution Medicines Inc Recent Activity New Position	5.46%	$23.826M 245,000 shares@ $97.25 avg price	New Position
RCUS Arcus Biosciences Inc Recent Activity Increased 14.37%	5.19%	$22.635M 1.048M shares@ $21.6 avg price	Increased 14.37%
IMCR Immunocore Holdings Plc-adr Recent Activity	4.72%	$20.58M 682,597 shares@ $30.16 avg price
CYTK Cytokinetics Inc Recent Activity New Position	4.53%	$19.773M 300,000 shares@ $65.91 avg price	New Position

1-10 of 26